市場調查報告書

前列腺肥大症治療藥的全球市場:2020年

Drugs For Benign Prostatic hypertrophy Global Market Report 2020

出版商 The Business Research Company 商品編碼 918137
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
Back to Top
前列腺肥大症治療藥的全球市場:2020年 Drugs For Benign Prostatic hypertrophy Global Market Report 2020
出版日期: 2019年12月09日內容資訊: 英文
簡介

本報告提供全球前列腺肥大症市場的相關調查,提供市場趨勢及策略,市場成長及阻礙因素,類型·終端用戶·各地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 摘要整理

第2章 市場特徵

第3章 市場規模及成長

  • 過去的市場
  • 市場預測
    • 市場成長要素
    • 市場阻礙因素

第4章 市場區隔

  • 各類型:過去/預測
    • AlphaBroker
    • 5-Alpha還原酵素抑制劑
    • 磷酸二酯酶-5抑制劑
    • 其他
  • 各終端用戶:過去/預測
    • 院內藥局
    • 零售藥局
    • 線上藥局

第5章 市場分析:各區各國

  • 市場過去/預測:各地區
  • 市場過去/預測:各國

第6章 亞太地區市場

  • 市場概要
  • 市場過去/預測:各類型
  • 市場過去/預測:各終端用戶

第7章 中國市場

第8章 印度市場

第9章 日本市場

第10章 澳洲市場

第11章 印尼市場

第12章 韓國市場

第13章 西歐市場

第14章 英國市場

第15章 德國市場

第16章 法國市場

第17章 東歐市場

第18章 俄羅斯市場

第19章 北美市場

第20章 美國市場

第21章 南美市場

第22章 巴西市場

第23章 中東市場

第24章 非洲市場

第25章 競爭情形及企業簡介

  • 競爭情形
  • 企業簡介
    • Allergan PLC
    • Astellas Pharma Inc.
    • Boehringer Ingelheim
    • Eli Lilly and Company
    • GlaxoSmithKline PLC

第26章 主要合併及收購

第27章 市場趨勢及策略

第28章 產品平台分析

第29章 市場今後的預測及潛在力分析

第30章 附錄

  • 簡稱
  • 貨幣
  • 調查相關諮詢方式
  • 商務調查企業
  • 著作權及免責聲明
目錄

Drugs For Benign Prostatic hypertrophy Market Global Report 2020 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the global drugs for benign prostatic hypertrophy market.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Description:

Where is the largest and fastest growing market for the drugs for benign prostatic hypertrophy? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Drugs For Benign Prostatic hypertrophy Market Global Report from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market.

  • The Market Characteristics section of the report defines and explains the market.
  • The Market Size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
  • Market Segmentations break down market into sub markets.
  • The Regional and Country section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
  • Competitive Landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The Trends and Strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.

Scope

Markets Covered: 1) By Type: Alpha Blocker, 5-alpha Reductase Inhibitor, Phosphodiesterase-5 Inhibitor, Others 2) By End User: Hospital Pharmacies, Retail Pharmacies, Others

Companies Mentioned: Allergan PLC, Astellas Pharma Inc., Boehringer Ingelheim, Eli Lilly and Company, GlaxoSmithKline PLC

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time Series: Five years historic and forecast.

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Drugs for Benign Prostatic Hypertrophy Market Characteristics

3. Drugs for Benign Prostatic Hypertrophy Market Size And Growth

  • 3.1. Global Drugs for Benign Prostatic Hypertrophy Historic Market, 2015 - 2019, $ Billion
    • 3.1.1. Drivers Of The Market
    • 3.1.2. Restraints On The Market
  • 3.2. Global Drugs for Benign Prostatic Hypertrophy Forecast Market, 2019 - 2022F, 2025F, 2030F, $ Billion
    • 3.2.1. Drivers Of The Market
    • 3.2.2. Restraints On the Market

4. Drugs for Benign Prostatic Hypertrophy Market Segmentation

  • 4.1. Global Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
    • Alpha Blocker
    • 5-alpha Reductase Inhibitor
    • Phosphodiesterase-5 Inhibitor
    • Others
  • 4.2. Global Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies

5. Drugs for Benign Prostatic Hypertrophy Market Regional And Country Analysis

  • 5.1. Global Drugs for Benign Prostatic Hypertrophy Market, Split By Region, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 5.2. Global Drugs for Benign Prostatic Hypertrophy Market, Split By Country, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

6. Asia-Pacific Drugs for Benign Prostatic Hypertrophy Market

  • 6.1. Asia-Pacific Drugs for Benign Prostatic Hypertrophy Market Overview
  • 6.2. Asia-Pacific Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 6.3. Asia-Pacific Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

7. China Drugs for Benign Prostatic Hypertrophy Market

  • 7.1. China Drugs for Benign Prostatic Hypertrophy Market Overview
  • 7.2. China Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F,$ Billion
  • 7.3. China Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F,$ Billion

8. India Drugs for Benign Prostatic Hypertrophy Market

  • 8.1. India Drugs for Benign Prostatic Hypertrophy Market Overview
  • 8.2. India Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 8.3. India Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

9. Japan Drugs for Benign Prostatic Hypertrophy Market

  • 9.1. Japan Drugs for Benign Prostatic Hypertrophy Market Overview
  • 9.2. Japan Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 9.3. Japan Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

10. Australia Drugs for Benign Prostatic Hypertrophy Market

  • 10.1. Australia Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 10.2. Australia Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

11. Indonesia Drugs for Benign Prostatic Hypertrophy Market

  • 11.1. Indonesia Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 11.2. Indonesia Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

12. South Korea Drugs for Benign Prostatic Hypertrophy Market

  • 12.1. South Korea Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 12.2. South Korea Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

13. Western Europe Drugs for Benign Prostatic Hypertrophy Market

  • 13.1. Western Europe Drugs for Benign Prostatic Hypertrophy Market Overview
  • 13.2. Western Europe Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 13.3. Western Europe Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

14. UK Drugs for Benign Prostatic Hypertrophy Market

  • 14.1. UK Drugs for Benign Prostatic Hypertrophy Market Overview
  • 14.2. UK Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 14.3. UK Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

15. Germany Drugs for Benign Prostatic Hypertrophy Market

  • 15.1. Germany Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 15.2. Germany Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

16. France Drugs for Benign Prostatic Hypertrophy Market

  • 16.4. France Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 16.5. France Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

17. Eastern Europe Drugs for Benign Prostatic Hypertrophy Market

  • 17.1. Eastern Europe Drugs for Benign Prostatic Hypertrophy Market Overview
  • 17.2. Eastern Europe Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 17.3. Eastern Europe Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

18. Russia Drugs for Benign Prostatic Hypertrophy Market

  • 18.1. Russia Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 18.2. Russia Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

19. North America Drugs for Benign Prostatic Hypertrophy Market

  • 19.1. North America Drugs for Benign Prostatic Hypertrophy Market Overview
  • 19.2. North America Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 19.3. North America Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

20. USA Drugs for Benign Prostatic Hypertrophy Market

  • 20.1. USA Drugs for Benign Prostatic Hypertrophy Market Overview
  • 20.2. USA Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 20.3. USA Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

21. South America Drugs for Benign Prostatic Hypertrophy Market

  • 21.1. South America Drugs for Benign Prostatic Hypertrophy Market Overview
  • 21.2. South America Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 21.3. South America Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

22. Brazil Drugs for Benign Prostatic Hypertrophy Market

  • 22.1. Brazil Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 22.2. Brazil Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

23. Middle East Drugs for Benign Prostatic Hypertrophy Market

  • 23.1. Middle East Drugs for Benign Prostatic Hypertrophy Market Overview
  • 23.2. Middle East Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 23.3. Middle East Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

24. Africa Drugs for Benign Prostatic Hypertrophy Market

  • 24.1. Africa Drugs for Benign Prostatic Hypertrophy Market Overview
  • 24.2. Africa Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 24.3. Africa Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

25. Drugs for Benign Prostatic Hypertrophy Market Competitive Landscape And Company Profiles

  • 25.1. Drugs for Benign Prostatic Hypertrophy Market Competitive Landscape
  • 25.2. Drugs for Benign Prostatic Hypertrophy Market Company Profiles
    • 25.2.1. Allergan PLC
      • 25.2.1.1. Overview
      • 25.2.1.2. Products and Services
      • 25.2.1.3. Strategy
      • 25.2.1.4. Financial Performance
    • 25.2.2. Astellas Pharma Inc.
      • 25.2.2.1. Overview
      • 25.2.2.2. Products and Services
      • 25.2.2.3. Strategy
      • 25.2.2.4. Financial Performance
    • 25.2.3. Boehringer Ingelheim
      • 25.2.3.1. Overview
      • 25.2.3.2. Products and Services
      • 25.2.3.3. Strategy
      • 25.2.3.4. Financial Performance
    • 25.2.4. Eli Lilly and Company
      • 25.2.4.1. Overview
      • 25.2.4.2. Products and Services
      • 25.2.4.3. Strategy
      • 25.2.4.4. Financial Performance
    • 25.2.5. GlaxoSmithKline PLC
      • 25.2.5.1. Overview
      • 25.2.5.2. Products and Services
      • 25.2.5.3. Strategy
      • 25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Drugs for Benign Prostatic Hypertrophy Market

27. Drugs for Benign Prostatic Hypertrophy Market Trends And Strategies

28. Product Pipeline Analysis

29. Drugs for Benign Prostatic Hypertrophy Market Future Outlook and Potential Analysis

30. Appendix

  • 30.1. Abbreviations
  • 30.2. Currencies
  • 30.3. Research Inquiries
  • 30.4. The Business Research Company
  • 30.5. Copyright And Disclaimer
Back to Top